FDA approval adds almost $200m to Neuren value says CEO

SYDNEY: The ASX’s top performing health stock for 2022 is set for another ... read more

Grim diagnosis as cancer hopeful now struggles offshore

BRISBANE: GenesisCare was meant to be the next CSL. It even had the ... read more

Jarden pops up in TPG Capital’s camp at InvoCare

MELBOURNE: US private equity giant TPG Capital has called in extra troops at ... read more

Retail Food Group brokers to recast terms of equity raising

SYDNEY: Brokers were forced to return to shareholders of Retail Food Group with ... read more